Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine.
Genvresse
I
I
Flath
B
B
Akrivakis
K
K
Beinert
T
T
Späth-Schwalbe
E
E
Possinger
K
K
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003879:Dermatologic Agents / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014750:Vincristine / Q000008:administration & dosage; D000077235:Vinorelbine; D000093542:Gemcitabine
D003879:Dermatologic Agents; D003841:Deoxycytidine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D000077235:Vinorelbine; D000093542:Gemcitabine